BackConcert Pharmaceuticals Overview

Concert Pharmaceuticals Profit Margin

Profitability ratio analysis for CNCE.

Quarterly Profit Margin

-352525.00%
↓ 7075.24% YoY

As of Sep 2022

Annual Profit Margin (TTM)

-117455.64%
↓ 57593.40% YoY

Trailing 12 months ending Sep 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin